General Hepatology Update: Contemporary Management of Advanced Liver Diseases—From Metabolic Dysfunction–Associated Steatohepatitis Therapies to Decompensated Cirrhosis
Nov
2026
Description
Join this comprehensive educational program designed to equip clinicians and advanced practice providers with practical, evidence-based approaches across the spectrum of advanced liver disease. Through 3 focused presentations, the program addresses the optimal use of newly approved metabolic dysfunction–associated steatohepatitis therapies; key updates in hepatocellular carcinoma surveillance and management; and contemporary strategies for caring for patients with decompensated cirrhosis. Speakers emphasize clinical decision-making, integration of noninvasive testing, multidisciplinary care, and translating recent advances into everyday practice for hepatologists and the broader liver care team.
Presentations
8:00 AM
- 8:25 AM
Convention Center - Bluebird Ballroom 2DEF
Hepatocellular Carcinoma: Key Updates in Surveillance, Diagnosis, and Management
Sudha Kodali, MD, MSPH | Presenter
8:25 AM
- 8:50 AM
Convention Center - Bluebird Ballroom 2DEF
Approved Metabolic Dysfunction–Associated Steatohepatitis Therapies: Which Treatment Should I Use—and When?
Meena B Bansal, MD, FAASLD | Presenter
8:50 AM
- 9:15 AM
Convention Center - Bluebird Ballroom 2DEF
Management of Decompensated Cirrhosis: Practical Approaches and Evolving Strategies
Jennifer C Lai, MD, MBA | Presenter